ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
A selection of thought leadership materials from ICON experts on Decentralised & Hybrid Clinical Trials
- Pragmatic steps to using mobile technology in clinical trials - Will COVID-19 bring lasting change in clinical trial practices? - eBook: Digital acceleration in clinical trials
The effect of Covid-19 solutions on the clinical trials process
Shelley McLendon, VP of Project Management, Vaccines and Infectious Diseases, outlines best practices that can keep trials running at optimal speed and efficiency, and the benefits of adopting a strategic partnership.
A challenge of pandemic proportions
ICON CEO Steve Cutler, discusses running the Pfizer / BioNTech vaccine trial, and how it proved the value of partnership, and the key role of technology.
The Irish Times Business Person of the Month: Steve Cutler
ICON CEO Steve Cutler has been chosen as The Irish Times Business Person of the Month for February 2021.
US Regulators question AstraZeneca vaccine trial data
ICON's Dr. Andrew Garrett, Executive Vice President of Scientific Operations, weighs in on potential safety issues with the AstraZeneca COVID-19 vaccine.
What does it really take to conduct a vaccine trial at scale?
Dr Nuala Murphy, President of Clinical Services, talks exclusively to Pharmafield about the Pfizer / BioNTech COVID-19 vaccine trial and the implications this has on the future of drug development.
International Women's Day: An interview with Cindy Spittle
In this interview, Cindy Spittle talks about the women role models who provided inspiration in her career in honour of International Women's Day.
International Women's Day: An interview with Marelise Epstein
Marelise Epstein is interviewed for International Women's Day and provides a glimpse into her work day and what inspires her.
Steve Cutler: ‘People understand what a clinical trial is now’
An interview with CEO Steve Cutler on ICON's recent acquisition of PRA Health Sciences.
Inside the Pfizer/BioNTech COVID-19 vaccine trial: ‘We knew the world was watching and waiting for results’
An article featuring commentary from Dr. Nuala Murphy on ICON’s learnings from conducting the Pfizer/BioNTech trial.